Research programme: bacterial DNA gyrase inhibitors - Vertex
Alternative Names: VRT-125853; VRT-752586; VX-692; VX-883Latest Information Update: 04 Nov 2017
At a glance
- Originator Vertex Pharmaceuticals
- Class Benzimidazoles
- Mechanism of Action DNA gyrase inhibitors; DNA topoisomerase IV inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Bacterial infections